While the findings in Tables 1 and 2 cover a broad area of past and current investigations into survivin’s mechanisms of action, further study is needed in many of the identified subareas in order for the findings to be of practical use for molecular cancer therapeutics. This evidence concerns the gene BIRC5 and cancer.